Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_assertion type Assertion NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_head.
- NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_assertion description "[These data are validated by an increased CD62L expression in the bone marrow of patients (n=6) with advanced CML who received imatinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_provenance.
- NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_assertion evidence source_evidence_literature NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_provenance.
- NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_assertion SIO_000772 12714574 NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_provenance.
- NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_assertion wasDerivedFrom befree-2016 NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_provenance.
- NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_assertion wasGeneratedBy ECO_0000203 NP392261.RAVAcM66H5VgCW9vs-95UAVgByPKkK7REU6ZumYPDuzmk130_provenance.